Hexacyclonate (Gevilon) is a
stimulant drug. It has been used for the treatment of
alcoholism[1] and for increasing motivation in elderly patients,[2] but Gevilon (containing a different active substance -
gemfibrozil) is now mainly used for the treatment of
hyperlipoproteinaemia.[3][4] It is chemically similar to the anticonvulsant
gabapentin, with a hydroxyl group replacing the amine.
The latter use may be incorrectly assigned, as "Gevilon" has been used as a trade name for
gemfibrozil, a well-known drug for dislypidemia.
References
^Chesrow EJ, Sabatini R, Musci JP, Kaplitz SE, Marquardt GH (May 1962). "Adjunctive treatment of the chronic alcoholic with hexacyclonate sodium". The Illinois Medical Journal. 121: 546–8.
PMID13878809.
^Morrison BO (January 1962). "Pharmaco-motivation of the geriatric patient: a preliminary report on hexacyclonate". The Journal of the Louisiana State Medical Society. 114: 23–6.
PMID14476295.
^Milewicz A, Plamieniak Z, Bohdanowicz-Pawlak A (1992). "Therapeutic effect of gevilon in patients with hyperlipoproteinaemia". Materia Medica Polona. Polish Journal of Medicine and Pharmacy. 24 (2): 91–5.
PMID1307777.
^Gazdikova K, Korecka P, Springer V, Gazdik F (2003). "Pharmacoeconomic aspects of patients treated by hemodialysis". Bratislavske Lekarske Listy. 104 (10): 329–34.
PMID15055734.